Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)
It uses a more traditional gene therapy technique in which the outer shell of a small virus called an adeno-associated virus slips DNA into cells and givens them the instructions to make GLP-1
The refund policy includes empty bottles, which is a consumer-friendly feature - but the same page shows both "60 Days" and "180 Days" guarantee language without explaining the discrepancy, so confirm which applies before you buy
[DOI] [PMC free article] [PubMed] [Google Scholar] 47.Averill-Bates D.A
Eventually, the small pouch will be able to hold 8 ounces of food
